Liberals' political will on pharmacare questioned as minister promises progress
Health Minister Jean-Yves Duclos says the government's plans for pharmacare are moving forward, but experts who study government drug plans suggest the Liberals may have lost the political will to take bold steps toward a national program.
People like Marc-Andre Gagnon were still holding out hope that spending would be set aside in Tuesday's federal budget to create a national, single-payer drug plan.
But though the Carleton University health policy professor said he was optimistic, he also admitted he wasn't surprised when there was no mention of pharmacare in the document.
"We don't see the political willingness anymore," Gagnon said in an interview Friday.
Progress on pharmacare is one of the conditions of the confidence-and-supply agreement the NDP entered with the Liberals last year, in which the NDP throws its support behind the government on key confidence votes in exchange for progress on the party's priorities.
Under the agreement, the government has until the end of this year to pass some kind of pharmacare legislation, and must put together a national list of essential medicines and a plan for bulk purchasing by 2025.
Duclos said in no uncertain terms that progress on the file will continue -- but that progress is likely to be incremental.
"We're making steps moving forward. But we'll have to proceed step by step," he said in an interview, adding that first, the cost of drugs needs to be driven down and medications need to be made more accessible.
One of those early steps was the launch of the National Strategy for Drugs for Rare Diseases last month, which committed $1.5 billion toward improving the access to and affordability of effective drugs for rare diseases over three years.
Duclos called it "an important signal to what we are looking to do in the longer term."
But there's no denying that government enthusiasm for a national drug program has tempered significantly over the last several years. What began as a legacy-making policy proposal for the Liberals in 2015 now rarely gets a mention on Parliament Hill, as other health concerns have crowded the national conversation.
The health minister's office was consumed with the pandemic and the health-care crisis that followed, and the department has also been busy with another condition of the Liberals' deal with the NDP: national dental insurance for uninsured low- and middle-income families.
"With the pandemic, everything was put on hold, and basically, they never got back to this issue of a national prescription drug plan, even if they have all the tools," Gagnon said.
Making headway on pharmacare now would likely mean spending money the government can't spare anymore, Simon Fraser University health policy professor Steven Lewis said in an interview.
"There would probably have to be a new tranche of money, which I don't see forthcoming anytime soon given that this deficit is a bit bigger than was anticipated," Lewis said.
In 2017, the Parliamentary Budget Officer estimated a pharmacare plan would cost $19.3 billion per year if it had been implemented in 2015, and would grow over time to cost $22.6 billion. In today's dollars, the annual cost would be between $23 billion and $27 billion.
At the same time, overall spending on drugs -- between governments, insurance companies and Canadians -- would be expected to drop by $4.4 billion as a result of better purchasing power.
Lewis said it's difficult to know how much pharmacare would cost before knowing exactly how the government plans to do it. For example, the government could choose to tax employers who previously offered drug benefits to recoup some of the cost.
In 2019, the government got a detailed road map to guide the path toward a national pharmacare program, which recommended starting with essential drugs first.
That report, put together by a National Advisory Council led by Dr. Eric Hoskins, suggested the initial public spending increase would be roughly $4.1 billion if it was implemented in 2022, and would grow to cost $38.5 billion by 2027 as the list of covered drugs expanded.
Aside from the cost pressures, both Lewis and Gagnon said the government may be facing pushback from the pharmaceutical industry.
Changes to the way drug prices are set at the Patented Medicine Prices Review Board have been met with resistance from industry and patient groups who worry that lower prices will affect access to new drug therapies in Canada.
"A genuine pan-Canadian, fully medicare-inclusive pharmacare program is going to create some winners and losers with pharma," said Lewis, who explained there would likely be firmer price negotiations and clampdowns on off-label drug use.
But while critics suggest the government is dragging its feet, Duclos characterizes it as carefully laying the groundwork.
Pharmacare "is done better when we have better access, better affordability and better knowledge of how to use drugs in Canada," Duclos said.
He added that there's still a lot to do before figuring out the next step, to make sure each stride toward long-term pharmacare is the right one.
This report by The Canadian Press was first published April 1, 2023.
CTVNews.ca Top Stories
Prison service to review decision to transfer killer Bernardo to medium security
The federal prison service says it will have a second look at its decision to move convicted killer Paul Bernardo to a medium-security facility as political leaders of all stripes react to the news with shock and outrage.

Poilievre threatens to filibuster budget bill if Liberals don't meet demands
Conservative Leader Pierre Poilievre is threatening to use procedural tools to delay passage of the federal budget in the House of Commons if the Liberals don't meet his demands.
About ducking time: Apple to tweak iPhone autocorrect function
One of the most notable happenings at Apple's event for developers on Monday is likely the iPhone maker's tweak that will keep its autocorrect feature from annoyingly correcting one of the most common expletives to 'ducking.'
Canada facing critical shortages of leukemia and thyroid cancer drugs
Canada is currently facing a critical shortage of drugs used to fight thyroid cancer and a form of leukemia.
Small-brained ancient human cousins may have buried their dead, according to a surprising study
An ancient human cousin may have buried its dead and carved symbols into cave walls, surprising findings for a creature with a small brain.
Facing evacuations due to a forest fire or flood? Here’s what to pack in a grab-and-go bag
While some natural disasters or bouts of extreme weather may require sheltering in place until authorities can restore power to the area, others require residents to evacuate quickly, sometimes in a matter of hours — and if you want to be prepared, you should create a grab-and-go bag.
Poor air quality, evacuations in multiple provinces due to wildfires
Wildfire smoke prompted warnings about poor air quality for many regions across the country, stretching from northern Alberta to the Atlantic.
Data shows COVID-19 hospitalizations, severe outcomes continue to decline, but we must remain vigilant: experts
Wastewater testing, hospitalization and death data from COVID-19 tell us the virus' spread continue to trend downward in Canada. But we're not at the end, and public health experts say we must heed lessons learned from the pandemic and remain vigilant. Read the analysis on CTVNews.ca.
Apple unveils sleek 'Vision Pro' goggles. Will it be what VR has been looking for?
Apple on Monday unveiled a long-rumoured headset that will place its users between the virtual and real world, while also testing the technology trendsetter's ability to popularize new-fangled devices after others failed to capture the public's imagination
W5 HIGHLIGHTS
W5 Investigates | What's driving limb-lengthening surgery -- a radical procedure making men taller
A growing number of men are undergoing a radical surgery to become taller. CTV W5 goes inside the lucrative world of limb-lengthening surgery.

Shrinking coastlines: Will more Canadians have to move because of climate change?
Post tropical storm Fiona showed how quickly Canadians can be displaced by climate change. W5 looks into whether more people living in vulnerable areas will have to consider moving in the years to come.

W5 EXCLUSIVE | Interviewing a narco hitman: my journey into Mexico's cartel heartland
W5 goes deep into the narco heartland to interview a commander with one of Mexico's most brutal cartels.

W5 Investigates | Daniel Jolivet insists he's not a murderer and says he has proof
Convicted murderer Daniel Jolivet, in prison for the past 30 years, has maintained his innocence since the day he was arrested. W5 reviews the evidence he painstakingly assembled while behind bars.
I met the 'World's Tallest Teenager' and his basketball career is just taking off
W5 Producer Shelley Ayres explains how she was in awe to meet what the Guinness Book of World Record's has named the World's Tallest Teenager, a 17-year-old from Quebec who plays for Team Canada.
W5 Investigates | Pivot Airlines crew seeking justice after 'cocaine cargo' detainment
CTV W5 investigates what authorities knew about plans to smuggle cocaine out of the Dominican Republic on a Toronto-bound Pivot Airlines flight. The airline's crew is demanding justice following their eight-month detention.
W5 profile | This Canadian helped write some of Carrie Underwood's biggest hits – here's how he does it
Gordie Sampson has written hit songs for some of the biggest names in country music, including Carrie Underwood and Luke Bryan. CTV W5 speaks with the Grammy winner from small-town Nova Scotia about his creative process.
W5 EXCLUSIVE | W5 exposes the drug connections and money trail in the Pivot Airlines story
On CTVNews.ca, W5 exposes the suspicious company chartering a Pivot Airlines flight that ended up with 210 kilograms of cocaine onboard.